http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017368107-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d1b37af041ed385e56d2002106bf108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d0285455363f9b4d584cd1e17f69f6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7eca3a841facfce3f3d369facca8e66d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6f6d194f63c503d7ace8121df7be7bd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K4-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-54
filingDate 2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ad4a22fc230c1ee63872586783d61a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dee6208398f8db7c39334ed90015466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d04219601d59bdd90bd6d273bef3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d06513a35c06e636f640948614892c0
publicationDate 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2017368107-B2
titleOfInvention Compounds for treatment of senescence-related disorders
abstract The present invention relates to compounds of general formula (I) in particular for use in the treatment of senescence-related diseases, such as idiopathic pulmonary fibrosis, sarcopenia, diabetes, obesity, osteoarthritis, chronic inflammations, glaucoma, cataracts, radiation-induced oral mucosis, renal transplantation, prostatic hyperplasia.
priorityDate 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014173374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015151001-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467950482

Total number of triples: 33.